Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders

Archives of General Psychiatry

Volumn 68, Issue 11, 2011, Pages 1158-1167

  Hasin, Deborah ^a,b,c   Fenton, Miriam C ^b,c   Skodol, Andrew ^a,d   Krueger, Robert ^e   Keyes, Katherine ^b,c   Geier, Timothy ^c   Greenstein, Eliana ^c   Blanco, Carlos ^a,c   Grant, Bridget ^f  

^a Columbia University ^*  (United States)

^b New York State Psychiatric Institute ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; NICOTINE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BORDERLINE STATE; CANNABIS ADDICTION; COMPULSIVE PERSONALITY DISORDER; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NARCISSISM; PERSONALITY DISORDER; PSYCHOPATHY; SCHIZOIDISM; SCHIZOTYPAL PERSONALITY DISORDER; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; ALCOHOLISM; COMORBIDITY; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PERSONALITY DISORDERS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; TOBACCO USE DISORDER;

EID: 80755169343     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2011.136     Document Type: Article

References (111)

1. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(7):830-842. (Pubitemid 47026379)
2. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(11):1107-1115. (Pubitemid 39463411)
3. Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA. 2004;291(17):2114-2121. (Pubitemid 38580155)
4. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(5):566-576. (Pubitemid 46718289)
5. John U, Meyer C, Rumpf H-J, Hapke U. Smoking, nicotine dependence and psychiatric comorbidity: a population-based study including smoking cessation after three years. Drug Alcohol Depend. 2004;76(3):287-295. (Pubitemid 39556358)
6. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295(17):2003-2017. (Pubitemid 44794003)
7. McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689-1695.
8. Milne BJ, Caspi A, Harrington H, Poulton R, Rutter M, Moffitt TE. Predictive value of family history on severity of illness: the case for depression, anxiety, alcohol dependence, and drug dependence. Arch Gen Psychiatry. 2009;66(7):738-747.
9. Hasin D, Paykin A, Endicott J. Course of DSM-IV alcohol dependence in a community sample: effects of parental history and binge drinking. Alcohol Clin Exp Res. 2001;25(3):411-414. (Pubitemid 32221821)
10. Nunes EV, Levin FR. Treatment of co-occurring depression and substance dependence: using meta-analysis to guide clinical recommendations. Psychiatr Ann. 2008;38(11):nihpa128505.
11. Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, Breslau N, Brown RA, George TP, Williams J, Calhoun PS, Riley WT. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 2008;10(12):1691-1715.
12. Piper ME, Smith SS, Schlam TR, Fleming MF, Bittrich AA, Brown JL, Leitzke CJ, Zehner ME, Fiore MC, Baker TB. Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol. 2010;78(1):13-23.
13. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J. Smoking, smoking cessation, and major depression. JAMA. 1990;264(12):1546- 1549. (Pubitemid 20303384)
14. Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello LR, Michael J. The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry. 1998;55(3):259-265.
15. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59(4):375-380. (Pubitemid 34275256)
16. Kushner MG, Abrams K, Thuras P, Hanson KL, Brekke M, Sletten S. Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcohol Clin Exp Res. 2005;29(8):1432-1443. (Pubitemid 41243368)
17. Compton WM III, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry. 2003;160(5):890-895. (Pubitemid 41079573)
18. Davidson KM, Blackburn IM. Co-morbid depression and drinking outcome in those with alcohol dependence. Alcohol Alcohol. 1998;33(5):482-487. (Pubitemid 28477181)
19. Keuthen NJ, Niaura RS, Borrelli B, Goldstein M, DePue J, Murphy C, Gastfriend D, Reiter SR, Abrams D. Comorbidity, smoking behavior and treatment outcome. Psychother Psychosom. 2000;69(5):244-250.
20. Crowley TJ, Mikulich SK, MacDonald M, Young SE, Zerbe GO. Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcome. Drug Alcohol Depend. 1998;49(3):225-237. (Pubitemid 28156230)
21. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Sociopathy and psychotherapy outcome. Arch Gen Psychiatry. 1985;42(11):1081-1086. (Pubitemid 16220677)
22. Rohde P, Kahler CW, Lewinsohn PM, Brown RA. Psychiatric disorders, familial factors, and cigarette smoking, III: associations with cessation by young adulthood among daily smokers. Nicotine Tob Res. 2004;6(3):509-522. (Pubitemid 38967540)
23. Haro G, Mateu C, Martínez-Raga J, Valderrama JC, Castellano M, Cervera G. The role of personality disorders on drug dependence treatment outcomes following inpatient detoxification. Eur Psychiatry. 2004;19(4):187-192. (Pubitemid 38766130)
24. Neufeld KJ, Kidorf MS, Kolodner K, King VL, Clark M, Brooner RK. A behavioral treatment for opioid-dependent patients with antisocial personality. J Subst Abuse Treat. 2008;34(1):101-111. (Pubitemid 350216357)
25. Kranzler HR, Del Boca FK, Rounsaville BJ. Comorbid psychiatric diagnosis predicts three-year outcomes in alcoholics: a posttreatment natural history study. J Stud Alcohol. 1996;57(6):619-626. (Pubitemid 26365617)
26. Pulay AJ, Stinson FS, Ruan WJ, Smith SM, Pickering RP, Dawson DA, Grant BF. The relationship of DSM-IV personality disorders to nicotine dependence - results from a national survey. Drug Alcohol Depend. 2010;108(1-2):141-145.
27. Pulay AJ, Stinson FS, Dawson DA, Goldstein RB, Chou SP, Huang B, Saha TD, Smith SM, Pickering RP, Ruan WJ, Hasin DS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: results from the wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Prim Care Companion J Clin Psychiatry. 2009;11(2):53-67.
28. Stinson FS, Dawson DA, Goldstein RB, Chou SP, Huang B, Smith SM, Ruan WJ, Pulay AJ, Saha TD, Pickering RP, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV narcissistic personality disorder: results from the wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(7):1033-1045. (Pubitemid 352031585)
29. Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, Smith SM, Dawson DA, Pulay AJ, Pickering RP, Ruan WJ. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(4):533-545. (Pubitemid 351792327)
30. Pulay AJ, Dawson DA, Ruan WJ, Pickering RP, Huang B, Chou SP, Grant BF. The relationship of impairment to personality disorder severity among individuals with specific Axis I disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Pers Disord. 2008;22(4):405-417.
31. Skodol AE, Oldham JM, Gallaher PE. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders. Am J Psychiatry. 1999;156(5):733-738. (Pubitemid 29220071)
32. Zanarini MC, Frankenbur FR, Weingeroff JL, Reich DB, Fitzmaurice GM, Weiss RD. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. Addiction. 2011;106(2):342-348.
33. Walter M, Gunderson JG, Zanarini MC, Sanislow CA, Grilo CM, McGlashan TH, Morey LC, Yen S, Stout RL, Skodol AE. New onsets of substance use disorders in borderline personality disorder over 7 years of follow-ups: findings from the Collaborative Longitudinal Personality Disorders Study. Addiction. 2009;104(1):97-103.
34. Jansson I, Hesse M, Fridell M. Influence of personality disorder features on social functioning in substance-abusing women five years after compulsive residential treatment. Eur Addict Res. 2009;15(1):25-31.
35. Grant BF, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP. Cooccurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(4):361-368. (Pubitemid 38451545)
36. Grant BF, Goldstein RB, Chou SP, Huang B, Stinson FS, Dawson DA, Saha TD, Smith SM, Pulay AJ, Pickering RP, Ruan WJ, Compton WM. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2009;14(11):1051-1066.
37. Grant BF, Dawson DA, Stinson FS, Chou PS, Kay W, Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71(1):7-16. (Pubitemid 36734856)
38. Ruan WJ, Goldstein RB, Chou SP, Smith SM, Saha TD, Pickering RP, Dawson DA, Huang B, Stinson FS, Grant BF. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2008;92(1-3):27-36. (Pubitemid 350218195)
39. Grant BF, Harford TC, Dawson DA, Chou PS, Pickering RP. The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39(1):37-44.
40. Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004;161(11):1967-1977. (Pubitemid 39441395)
41. Haney M. The marijuana withdrawal syndrome: diagnosis and treatment. Curr Psychiatry Rep. 2005;7(5):360-366. (Pubitemid 41684183)
42. Hasin DS, Keyes KM, Alderson D, Wang S, Aharonovich E, Grant BF. Cannabis withdrawal in the United States: results from NESARC. J Clin Psychiatry. 2008;69(9):1354-1363.
43. American Psychiatric Association. DSM-5 development: cannabis withdrawal. http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=430. Accessed March 27, 2011.
44. Canino G, Bravo M, Ramírez R, Febo VE, Rubio-Stipec M, Fernández RL, Hasin D. The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J Stud Alcohol. 1999;60(6):790-799. (Pubitemid 29526544)
45. Chatterji S, Saunders JB, Vrasti R, Grant BF, Hasin D, Mager D. Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule-Alcohol/Drug-Revised (AUDADIS-ADR): an international comparison. Drug Alcohol Depend. 1997;47(3):171-185. (Pubitemid 27412330)
46. Hasin D, Carpenter KM, McCloud S, Smith M, Grant BF. The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997;44(2-3):133-141. (Pubitemid 27129506)
47. Hasin D, Paykin A. Alcohol dependence and abuse diagnoses: concurrent validity in a nationally representative sample. Alcohol Clin Exp Res. 1999;23(1):144-150. (Pubitemid 29068479)
48. Hasin DS, Grant B, Endicott J. The natural history of alcohol abuse: implications for definitions of alcohol use disorders. Am J Psychiatry. 1990;147(11):1537-1541. (Pubitemid 20365448)
49. Hasin DS, Muthuen B, Wisnicki KS, Grant B. Validity of the bi-axial dependence concept: a test in the US general population. Addiction. 1994;89(5):573-579. (Pubitemid 24160085)
50. Hasin DS, Van Rossem R, McCloud S, Endicott J. Differentiating DSM-IV alcohol dependence and abuse by course: community heavy drinkers. J Subst Abuse. 1997;9:127-135. (Pubitemid 29381590)
51. Hasin DS, Schuckit MA, Martin CS, Grant BF, Bucholz KK, Helzer JE. The validity of DSM-IV alcohol dependence: what do we know and what do we need to know? Alcohol Clin Exp Res. 2003;27(2):244-252. (Pubitemid 36236647)
52. Cottler LB, Grant BF, Blaine J, Mavreas V, Pull C, Hasin D, Compton WM, Rubio-Stipec M, Mager D. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 1997;47(3):195-205. (Pubitemid 27412332)
53. Hasin D, Grant BF, Cottler L, Blaine J, Towle L, Ustün B, Sartorius N. Nosological comparisons of alcohol and drug diagnoses: a multisite, multi-instrument international study. Drug Alcohol Depend. 1997;47(3):217-226. (Pubitemid 27412334)
54. Nelson CB, Rehm J, Ustün TB, Grant B, Chatterji S. Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction. 1999;94(6):843-855. (Pubitemid 29286605)
55. Pull CB, Saunders JB, Mavreas V, Cottler LB, Grant BF, Hasin DS, Blaine J, Mager D, Ustün BT. Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross-national study. Drug Alcohol Depend. 1997;47(3):207-216. (Pubitemid 27412333)
56. Üstün B, Compton W, Mager D, Babor T, Baiyewu O, Chatterji S, Cottler L, Göǧüş A, Mavreas V, Peters L, Pull C, Saunders J, Smeets R, Stipec M-R, Vrasti R, Hasin D, Room R, Van den Brink W, Regier D, Blaine J, Grant BF, Sartorius N. WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results [published correction appears in Drug Alcohol Depend. 1998;50(2):185-186]. Drug Alcohol Depend. 1997;47(3):161-169. (Pubitemid 27412329)
57. Vrasti R, Grant BF, Chatterji S, Ustün BT, Mager D, Olteanu I, Badoi M. Reliability of the Romanian version of the alcohol module of the WHO Alcohol Use Disorder and Associated Disabilities: Interview Schedule-Alcohol/Drug- Revised. Eur Addict Res. 1998;4(4):144-149. (Pubitemid 29004836)
58. Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Huang B. Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Psychiatr Res. 2005;39(1):1-9. (Pubitemid 39422280)
59. Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP. Prevalence, correlates, and disability of personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2004;65(7):948-958.
60. Spitzer RL, Williams JBW, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID), I: history, rationale, and description. Arch Gen Psychiatry. 1992;49(8):624-629.
61. Loranger AW, Sartorius N, Andreoli A, Berger P, Buchheim P, Channabasavanna SM, Coid B, Dahl A, Diekstra RF, Ferguson B, Jacobsberg LB, Mombour W, Pull C, Ono Y, Regier DA. The International Personality Disorder Examination: The World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration International Pilot Study of personality disorders. Arch Gen Psychiatry. 1994;51(3):215-224. (Pubitemid 24081510)
62. Zanarini MC, Frankenburg FR, Sickel AE, Yong L. The Diagnostic Interview for DSM-IV Personality Disorders. Belmont, MA: McLean Hospital, Laboratory for the Study of Adult Development; 1996.
63. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry. 1981;38(4):381-389. (Pubitemid 11156022)
64. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA, Sartorius N, Towle LH. The Composite International Diagnostic Interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45(12):1069-1077. (Pubitemid 19005460)
65. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. User's Guide for the Structured Clinical Interview for the DSM-IV Axis II Personality Disorders. Washington, DC: American Psychiatric Press; 1997.
66. Loranger AW. International Personality Disorder Examination: DSM-IV and ICD-10 Interviews. Odessa, FL: Psychological Assessment Resources, Inc; 1999.
67. Zimmerman M. Diagnosing personality disorders: a review of issues and research methods. Arch Gen Psychiatry. 1994;51(3):225-245. (Pubitemid 24081511)
68. Compton WM, Conway KP, Stinson FS, Colliver JD, Grant BF. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66(6):677-685. (Pubitemid 40942412)
69. Grant BF, Stinson FS, Dawson DA, Chou SP, Ruan WJ. Co-occurrence of DSM-IV personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Compr Psychiatry. 2005;46(1):1-5. (Pubitemid 39642795)
70. Heiman GA, Ogburn E, Gorroochurn P, Keyes KM, Hasin D. Evidence for a two-stage model of dependence using the NESARC and its implications for genetic association studies. Drug Alcohol Depend. 2008;92(1-3):258-266. (Pubitemid 350218204)
71. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807-816. (Pubitemid 39031120)
72. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097-1106. (Pubitemid 41396935)
73. Ware JE, Kosinkski M, Turner-Bowker D, Gandek B. How to Score Version 2 of the SF-12 Health Survey. Lincoln, RI: QualityMetric Incorporated; 2002.
74. Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry. 1999;56(10):921-926. (Pubitemid 29480128)
75. Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60(9):929-937. (Pubitemid 37122313)
76. Skodol AE, Gunderson JG, Pfohl B, Widiger TA, Livesley WJ, Siever LJ. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry. 2002;51(12):936-950. (Pubitemid 34607710)
77. Yen S, Shea MT, Sanislow CA, Grilo CM, Skodol AE, Gunderson JG, McGlashan TH, Zanarini MC, Morey LC. Borderline personality disorder criteria associated with prospectively observed suicidal behavior. Am J Psychiatry. 2004;161(7):1296-1298. (Pubitemid 38859183)
78. Ansell EB, Sanislow CA, McGlashan TH, Grilo CM. Psychosocial impairment and treatment utilization by patients with borderline personality disorder, other personality disorders, mood and anxiety disorders, and a healthy comparison group. Compr Psychiatry. 2007;48(4):329-336. (Pubitemid 46874360)
79. Eaton NR, Krueger RF, Keyes KM, Skodol AE, Markon KE, Grant BF, Hasin DS. Borderline personality disorder co-morbidity: relationship to the internalizing-externalizing structure of common mental disorders. Psychol Med. 2011;41(5):1041-1050.
80. Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev. 2000;20(2):235-253. (Pubitemid 30100434)
81. Grilo CM, Sanislow CA, Shea MT, Skodol AE, Stout RL, Gunderson JG, Yen S, Bender DS, Pagano ME, Zanarini MC, Morey LC, McGlashan TH. Two-year prospective naturalistic study of remission from major depressive disorder as a function of personality disorder comorbidity. J Consult Clin Psychol. 2005;73(1):78-85. (Pubitemid 40223895)
82. Grilo CM, Stout RL, Markowitz JC, Sanislow CA, Ansell EB, Skodol AE, Bender DS, Pinto A, Shea MT, Yen S, Gunderson JG, Morey LC, Hopwood CJ, McGlashan TH. Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study. J Clin Psychiatry. 2010;71(12):1629-1635.
83. Skodol AE, Grilo CM, Keyes KM, Geier T, Grant BF, Hasin DS. Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am J Psychiatry. 2011;168(3):257-264.
84. Dimeff LA, Linehan MM. Dialectical behavior therapy for substance abusers. Addict Sci Clin Pract. 2008;4(2):39-47.
85. Axelrod SR, Perepletchikova F, Holtzman K, Sinha R. Emotion regulation and substance use frequency in women with substance dependence and borderline personality disorder receiving dialectical behavior therapy. Am J Drug Alcohol Abuse. 2011;37(1):37-42.
86. van den Bosch LMC, Koeter MWJ, Stijnen T, Verheul R, van den Brink W. Sustained efficacy of dialectical behaviour therapy for borderline personality disorder. Behav Res Ther. 2005;43(9):1231-1241. (Pubitemid 40984744)
87. Ravndal E, Vaglum P. Psychopathology and substance abuse as predictors of program completion in a therapeutic community for drug abusers: a prospective study. Acta Psychiatr Scand. 1991;83(3):217-222.
88. Fenton MC, Geier T, Greenstein E, Keyes KM, Skodol AE, Krueger B, Grant BF, Hasin D. Psychiatric comorbidity and the persistence of drug use disorders in the United States. Addiction. In press.
89. Fridberg DJ, Vollmer JM, O'Donnell BF, Skosnik PD. Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Res. 2011;186(1):46-52.
90. Compton MT, Chien VH, Bollini AM. Associations between past alcohol, cannabis, and cocaine use and current schizotypy among first-degree relatives of patients with schizophrenia and non-psychiatric controls. Psychiatr Q. 2009;80(3):143-154.
91. Schiffman J, Nakamura B, Earleywine M, LaBrie J. Symptoms of schizotypy precede cannabis use. Psychiatry Res. 2005;134(1):37-42. (Pubitemid 40460971)
92. Bailey EL, Swallow BL. The relationship between cannabis use and schizotypal symptoms. Eur Psychiatry. 2004;19(2):113-114. (Pubitemid 38402273)
93. Dumas P, Saoud M, Bouafia S, Gutknecht C, Ecochard R, Daléry J, Rochet T, d'Amato T. Cannabis use correlates with schizotypal personality traits in healthy students. Psychiatry Res. 2002;109(1):27-35. (Pubitemid 34159307)
94. Nunn JA, Rizza F, Peters ER. The incidence of schizotypy among cannabis and alcohol users. J Nerv Ment Dis. 2001;189(11):741-748. (Pubitemid 33095522)
95. Esterberg ML, Goulding SM, McClure-Tone EB, Compton MT. Schizotypy and nicotine, alcohol, and cannabis use in a non-psychiatric sample. Addict Behav. 2009;34(4):374-379.
96. Esterberg ML, Jones EM, Compton MT, Walker EF. Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and nonpsychiatric controls. Schizophr Res. 2007;97(1-3):6-13. (Pubitemid 350088403)
97. Joseph S, Manafi E, Iakovaki A, Cooper R. Personality, smoking motivation, and self-efficacy to quit. Pers Individ Dif. 2003;34(5):749-758. (Pubitemid 36184914)
98. Larrison AL, Briand KA, Sereno AB. Nicotine, caffeine, alcohol and schizotypy. Pers Individ Differ. 1999;27:101-108.
99. Wiles NJ, Zammit S, Bebbington P, Singleton N, Meltzer H, Lewis G. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br J Psychiatry. 2006;188:519-526. (Pubitemid 43844098)
100. Richman JA. Occupational stress, psychological vulnerability and alcohol-related problems over time in future physicians. Alcohol Clin Exp Res. 1992;16(2):166-171.
101. Sonne SC, Nunes EV, Jiang H, Tyson C, Rotrosen J, Reid MS. The relationship between depression and smoking cessation outcomes in treatment-seeking substance abusers. Am J Addict. 2010;19(2):111-118.
102. Aubin HJ. Management of emergent psychiatric symptoms during smoking cessation. Curr Med Res Opin. 2009;25(2):519-525.
103. Richter KP, Ahluwalia HK, Mosier MC, Nazir N, Ahluwalia JS. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction. 2002;97(7):861-869. (Pubitemid 34729101)
104. Haas AL, Muñoz RF, Humfleet GL, Reus VI, Hall SM. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol. 2004;72(4):563-570. (Pubitemid 38988831)
105. Brown RA, Niaura R, Lloyd-Richardson EE, Strong DR, Kahler CW, Abrantes AM, Abrams D, Miller IW. Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine Tob Res. 2007;9(7):721-730. (Pubitemid 47009227)
106. Brown RA, Kahler CW, Niaura R, Abrams DB, Sales SD, Ramsey SE, Goldstein MG, Burgess ES, Miller IW. Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol. 2001;69(3):471-480. (Pubitemid 32667029)
107. Brooner RK, King VL, Kidorf M, Schmidt CW Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54(1):71-80. (Pubitemid 27044701)
108. McCrae RR, Costa PT Jr. Updating Norman's "Adequate Taxonomy": intelligence and personality dimensions in natural language and in questionnaires. J Pers Soc Psychol. 1985;49(3):710-721.
109. Costa PT, McCrae RR. The NEO-PI/NEO-FFI Manual Supplement. Odessa, FL: Psychological Assessment Resources, Inc; 1989.
110. Brooner RK, Schmidt CW, Herbst JH. Personality trait characteristics of opioid abusers with and without comorbid personality disorders. In: Costa PT Jr, Widiger TA, eds. Personality Disorders and the Five-Factor Model of Personality. ed 2. Washington, DC: American Psychological Association; 2002.
111. Feighner JP, Robins E, Guze SB, Woodruff RA Jr, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972;26(1):57-63.